NANOTOX 2014, 7th International Nanotoxicology Congress

NANOTOX 2014,第七届国际纳米毒理学大会

基本信息

项目摘要

DESCRIPTION (provided by applicant): Recent advances in nanotechnology have revolutionized all aspects of life, from engineering, semiconductors, building materials to cosmetics and nanomedicine. The unique physico-chemical characteristics combined with the vast surface area make the biological effects of nano-materials and their interactions with cells, tissues and biofluids largely unpredictable. The increasing use of engineered nanomaterials raises concerns about inadvertent exposure to these materials and the potential for adverse effects on human health and the environment. As a result of this, a new and explosively developing field of toxicology - nanotoxicology - has emerged. Experimental work in the field of nanotoxicology is progressing at exponential rate. In spite of this, there is still a fundamental lack of data on the potential impacts of nanomaterials n human health, and the environment, including natural ecosystems. Filling this gap of knowledge will require an unprecedented degree of national and international coordination between scientific organizations, regulatory agencies, and stakeholders. The proposed International Conference Nanotoxicology-2014 is an important step in this direction. The International Conference Nanotoxicology-2014 - to be held in Antalya, Turkey from April 23 through 26, 2014 - will bring together current research leaders in the field of toxicology of nanomaterial's from material scientists, chemists and manufacturers to molecular toxicologists, risk assessment experts as well as clinicians and translational scientists involved in biomedical applications of nanoparticles. Since 2006, when the first International conference on nanotoxicology has been initiated and organized in the US (Miami), a series of bi-annual meetings was conducted in Zurich (2008), Edinburgh (2010), and Beijing (2012). These conferences represented the major scientific events in the field of Nano toxicology whereby most innovative and significant breakthrough results in the emerging discipline were strategically disseminated and made available for the research community of scientists, representatives of nanomaterial's manufacturing industries, public health officials and experts in risk assessment/regulatory issues. The primary goal of the conference is to create the opportunity for cross disciplinary discussions for investigators with different fields of expertise working together to understand the chemistry, biology, molecular mechanisms of action and toxicity of nanomaterial's, hence to provide basis for risk assessments thus facilitating the design and production of nanomaterial's with minimized adverse effects on human health and the environment. The topics of the conference are focused on the latest most innovative areas of the exploding discipline of nanotoxicology: nanotoxicology and human toxicology, nano-environmental health and safety, eco-nanotoxicology, dose-response paradigm, molecular mechanisms of nontoxicity, immune responses to nanoparticles, nanomedicine, pharmacokinetics and particokinetics, nano-bio interface and nanobiomaterials, exposure scenarios and risk assessment of nanomaterials, systems biology approaches to nanosafety, In Silico modeling approaches including nano-QSARs, regulatory challenges of nanotechnology risks. A series of lectures on "Methods in nanosafety research" for young investigators will also be included in the program of the conference. Two special round-table discussions will be focused on the world-wide strategic research agenda in the field of nanosafety. Overall, the topics of the conference will address the major directions of research relevant to concerns associated with the environmental, occupational and biomedical exposures to nanomaterials. The conference will create opportunities for participants to present and share experiences, explore new directions and debate topics with experts from across the globe in the field of nanotoxicology.
描述(由申请人提供): 纳米技术的最新进展彻底改变了生活的各个方面,从工程,半导体,建筑材料到化妆品和纳米医学。独特的物理化学特性与广阔的表面积相结合,使纳米材料的生物学作用及其与细胞,组织和生物流体的相互作用在很大程度上是不可预测的。工程纳米材料的越来越多的使用引起了人们对这些材料无意接触以及对人类健康和环境产生不利影响的担忧。因此,出现了一个新的爆炸性发展的毒理学领域 - 纳米毒理学。纳米毒理学领域的实验性工作正在以指数率进行。尽管如此,仍然缺乏关于纳米材料N人类健康和环境(包括自然生态系统)的潜在影响的数据。填补这一知识的空白将需要科学组织,监管机构和利益相关者之间前所未有的国家和国际协调。拟议的国际会议纳米毒理学-2014是朝这个方向迈出的重要一步。 2014年国际会议纳米毒性学 - 将于2014年4月23日至2014年2月26日在土耳其的安塔利亚举行 - 将聚集在纳米材料毒理学领域的现有研究领导者,从材料,化学家和制造商到分子毒理学家,风险评估专家以及临床科学家以及涉及生物介绍的NANOPARPITYS的临床科学家和转化科学家。自2006年在美国(迈阿密)启动和组织了第一次国际纳米毒理学会议以来,在苏黎世(2008年),爱丁堡(2010年)和北京(2012年)举行了一系列两年的会议。这些会议代表了纳米毒理学领域的主要科学事件,在纳米毒理学领域中,最具创新性和重大突破的结果在新兴学科中得到了战略性传播,并为科学家,纳米材料制造工业,公共卫生,公共卫生官员,公共卫生官员,风险评估/监管问题的代表提供了研究社区。会议的主要目标是为具有不同专业知识领域的研究人员提供跨学科讨论的机会,以了解该领域 化学,生物学,纳米材料的作用和毒性的分子机制,因此为风险评估提供基础,从而促进纳米材料的设计和生产,对人类健康和环境的不利影响最小化。 The topics of the conference are focused on the latest most innovative areas of the exploding discipline of nanotoxicology: nanotoxicology and human toxicology, nano-environmental health and safety, eco-nanotoxicology, dose-response paradigm, molecular mechanisms of nontoxicity, immune responses to nanoparticles, nanomedicine, pharmacokinetics and在包括纳米QSARS,包括纳米QSAR的硅材料建模方法中,纳米材料的纳米材料,系统生物学方法的特定动力学,纳米生物生物界面和纳米材料,暴露情况和风险评估,系统生物学方法,纳米材料,纳米技术风险的监管挑战。会议计划中还将包括有关年轻研究人员的“纳米安全研究方法”的一系列讲座。两个特别的圆桌讨论将集中在纳米安全领域的全球战略研究议程上。总体而言,会议的主题将解决与与纳米材料的环境,职业和生物医学暴露有关的关注有关的研究的主要方向。该会议将为参与者创造机会,与来自纳米毒理学领域的全球专家展示和分享经验,探索新的方向和辩论主题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Valerian E Kagan其他文献

Role of coenzyme Q and superoxide in vitamin E cycling.
辅酶 Q 和超氧化物在维生素 E 循环中的作用。
  • DOI:
    10.1007/978-1-4899-1789-8_20
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Valerian E Kagan;Y. Tyurina;Y. Tyurina;Eric Witt
  • 通讯作者:
    Eric Witt
Sensitive and specific fluorescent probing of oxidative stress in different classes of membrane phospholipids in live cells using metabolically integrated cis-parinaric acid.
使用代谢整合的顺式石蜡油酸对活细胞中不同类别的膜磷脂中的氧化应激进行灵敏和特异的荧光探测。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Valerian E Kagan;Vladimir B. Ritov;Y. Tyurina;V. Tyurin
  • 通讯作者:
    V. Tyurin
Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells.
Bcl-2 在 PC12 大鼠嗜铬细胞瘤细胞中抗氧化作用的直接证据。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Y. Tyurina;V. Tyurin;Gianfranca Carta;P. Quinn;N. F. Schor;Valerian E Kagan
  • 通讯作者:
    Valerian E Kagan
beta-Carotene. An antioxidant or a target of oxidative stress in cells?
β-胡萝卜素。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Billy W. Day;Stefania Bergamini;Y. Tyurina;Gianfranca Carta;V. Tyurin;Valerian E Kagan
  • 通讯作者:
    Valerian E Kagan
Reduction of phenoxyl radicals of the antitumour agent etoposide (VP-16) by glutathione and protein sulfhydryls in human leukaemia cells: Implications for cytotoxicity.
人类白血病细胞中谷胱甘肽和蛋白巯基减少抗肿瘤药物依托泊苷 (VP-16) 的苯氧基自由基:对细胞毒性的影响。
  • DOI:
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    J. Yalowich;Y. Tyurina;V. Tyurin;William P. Allan;Valerian E Kagan
  • 通讯作者:
    Valerian E Kagan

Valerian E Kagan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Valerian E Kagan', 18)}}的其他基金

Therapeutic targeting MDSC-mediated immune suppression in cancer
针对癌症中 MDSC 介导的免疫抑制的治疗
  • 批准号:
    10540357
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
Therapeutic targeting MDSC-mediated immune suppression in cancer
针对癌症中 MDSC 介导的免疫抑制的治疗
  • 批准号:
    10340589
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
蛋白氧化磷脂相互作用决定上皮细胞命运和哮喘控制
  • 批准号:
    10593942
  • 财政年份:
    2020
  • 资助金额:
    $ 0.8万
  • 项目类别:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
促铁死亡脂氧合酶的选择性抑制剂 - 下一代放射减缓剂
  • 批准号:
    10176413
  • 财政年份:
    2020
  • 资助金额:
    $ 0.8万
  • 项目类别:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
促铁死亡脂氧合酶的选择性抑制剂 - 下一代放射减缓剂
  • 批准号:
    10408142
  • 财政年份:
    2020
  • 资助金额:
    $ 0.8万
  • 项目类别:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
蛋白氧化磷脂相互作用决定上皮细胞命运和哮喘控制
  • 批准号:
    10375454
  • 财政年份:
    2020
  • 资助金额:
    $ 0.8万
  • 项目类别:
The molecular basis of cardiolipin-protein interactions implicated in intrinsic apoptosis
心磷脂-蛋白质相互作用的分子基础涉及内在细胞凋亡
  • 批准号:
    9342976
  • 财政年份:
    2016
  • 资助金额:
    $ 0.8万
  • 项目类别:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
铁死亡作为肺损伤的死亡机制 - 项目 2
  • 批准号:
    10399560
  • 财政年份:
    2014
  • 资助金额:
    $ 0.8万
  • 项目类别:
Intra- and extra-cellular signaling by Cardiolipin in Lung injury
肺损伤中心磷脂的细胞内和细胞外信号传导
  • 批准号:
    8643330
  • 财政年份:
    2014
  • 资助金额:
    $ 0.8万
  • 项目类别:
Oxidative Lipidomics Core
氧化脂质组学核心
  • 批准号:
    8643333
  • 财政年份:
    2014
  • 资助金额:
    $ 0.8万
  • 项目类别:

相似国自然基金

基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
  • 批准号:
    51009131
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
  • 批准号:
    50178004
  • 批准年份:
    2001
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 0.8万
  • 项目类别:
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
  • 批准号:
    10642607
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Implementing Evidence-Based Treatment for Common Mental Disorders in HIV Clinics in Ukraine
在乌克兰艾滋病毒诊所对常见精神疾病实施循证治疗
  • 批准号:
    10762576
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Transovarial transmission of yersinia pestis in fleas
跳蚤中鼠疫耶尔森氏菌的跨卵巢传播
  • 批准号:
    10727534
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
将接受阿片类药物使用障碍治疗且吸烟的个体转至 SREC
  • 批准号:
    10661301
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了